Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Flyte Aviation, Inc.VTAK · Entity 8648 | Director | March 26, 2026 | March 30, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Flyte Aviation, Inc.
Report date March 26, 2026 · Filed March 30, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.15 · Expires 2036-03-26 | Direct | 40,000 |
Reported balance
After 2026-03-26 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-03-26 · Grant · Acquired 40,000 · Balance 40,000 F1: Options vest 100% on 180 day anniversary of grant date. |
Filing footnotes · ownership attribution and instrument terms
F1: Options vest 100% on 180 day anniversary of grant date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 26, 2026 Filed Mar 30, 2026 17:57 UTC | Flyte Aviation, Inc. VTAK · Entity 8648 | GrantOptions (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $1.15 | $0.00 |
DisclosureSEC source: 0001437749-26-010375 · rdgdoc.xml · derivative · entry 1 COLOMBATTO MARTIN J · CIK 0001208236 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2036-03-26 F1 · derivative.exercise_date: Options vest 100% on 180 day anniversary of grant date. Read SEC document |
| August 12, 2025 Filed Aug 14, 2025 16:33 UTC | Flyte Aviation, Inc. VTAK · Entity 8648 | GrantOptions (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $0.18 | $0.00 |
DisclosureSEC source: 0001654954-25-009659 · section16.xml · derivative · entry 1 COLOMBATTO MARTIN J · CIK 0001208236 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2035-08-12 F1 · derivative.exercise_date: Options vests 1/3 per year beginning on first anniversary of grant date. Read SEC document |
| January 29, 2025 Filed Jan 31, 2025 16:39 UTC | Flyte Aviation, Inc. VTAK · Entity 8648 | GrantStock Option · Derivative | 100,000 | $0.00 Strike: $0.42 | $0.00 |
DisclosureSEC source: 0001437749-25-002433 · rdgdoc.xml · derivative · entry 3 COLOMBATTO MARTIN J · CIK 0001208236 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2035-01-29 F2 · derivative.exercise_date: 33.33% exercisable on January 29, 2025, 33.33% exercisable on January 29, 2026, and 33.34% exercisable on January 29, 2027. Read SEC document |
| January 29, 2025 Filed Jan 31, 2025 16:39 UTC | Flyte Aviation, Inc. VTAK · Entity 8648 | SaleCommon Stock | 3 | $0.40 | $1.20 |
DisclosureSEC source: 0001437749-25-002433 · rdgdoc.xml · nonDerivative · entry 1 COLOMBATTO MARTIN J · CIK 0001208236 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · see footnote Disclosed balance after: 0 F1 · ownership.nature: Shares held of record by the M Colombatto Trust, for which the reporting person serves as trustee. Read SEC document |
| January 08, 2024 Filed Jan 10, 2024 16:31 UTC | Flyte Aviation, Inc. VTAK · Entity 8648 | GrantOptions (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $0.40 | $0.00 |
DisclosureSEC source: 0001654954-24-000421 · section16.xml · derivative · entry 1 COLOMBATTO MARTIN J · CIK 0001208236 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Underlying: Common stock · 25,000 shares Expires 2034-01-08 F1 · derivative.exercise_date: Options vests 8 1/3% every three months beginning on April 8, 2024. Read SEC document |
| June 04, 2021 Filed Jun 8, 2021 20:00 UTC | Flyte Aviation, Inc. RMED · Entity 8648 | GrantCommon Stock | 4,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-039047 · doc4.xml · nonDerivative · entry 1 COLOMBATTO MARTIN J · CIK 0001208236 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,439 F1 · shares: Reported shares represents a grant of restricted stock awards (the "RSAs") pursuant to Ra Medical Systems, Inc.'s 2018 Equity Incentive Plan. Each restricted stock award represents a contingent right to receive one share of Ra Medical Systems, Inc. common stock. The RSAs will vest on the earlier of (i) June 4, 2022, or (ii) the day prior to the date of the Stockholder's Annual Meeting next following June 4, 2021, subject to the reporting person's continued service. Read SEC document |
| January 05, 2021 Filed Jan 7, 2021 18:03 UTC | Flyte Aviation, Inc. RMED · Entity 8648 | GrantCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-002572 · doc4.xml · nonDerivative · entry 1 COLOMBATTO MARTIN J · CIK 0001208236 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,439 F1 · shares: The Reporting Person has elected to receive his 2021 retainer compensation in restricted stock, rather than cash. Subject to the Reporting Person continuing to be a "Service Provider" (as defined in the Company's 2018 Equity Incentive Plan) through each vesting date, the shares shall vest as follows: 25% of the shares subject to the restricted stock award shall vest quarterly on the fifth of the month immediately following the end of the quarter corresponding with the date of grant (i.e. April 5, 2021, July 5, 2021, October 5, 2021, and January 5, 2022), such that the shares shall be fully vested on January 5, 2022. Read SEC document |
| November 19, 2020 Filed Nov 19, 2020 18:25 UTC | Flyte Aviation, Inc. RMED · Entity 8648 | PurchaseCommon Stock | 8,700 | $5.78 | $50,279.04 |
DisclosureSEC source: 0001209191-20-059501 · doc4.xml · nonDerivative · entry 1 COLOMBATTO MARTIN J · CIK 0001208236 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,439 F1 · price: Represents the weighted average share price of an aggregate total of 8,700 shares purchased in the price range of $5.64 to $5.7999 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price. F2 · balance_after: On November 16, 2020, the common stock of the company reverse-split 25-for-1, resulting in the reporting persons ownership being reduced by 161,736. Read SEC document |
| October 12, 2020 Filed Oct 14, 2020 17:49 UTC | Flyte Aviation, Inc. RMED · Entity 8648 | GrantCommon Stock | 100,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-054817 · doc4.xml · nonDerivative · entry 1 COLOMBATTO MARTIN J · CIK 0001208236 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 168,475 F1 · shares: Reported shares represents a grant of restricted stock awards (the "RSAs") pursuant to Ra Medical Systems, Inc.'s 2018 Equity Incentive Plan. Each restricted stock award represents a contingent right to receive one share of Ra Medical Systems, Inc. common stock. The RSAs will vest on the earlier of (i) October 12, 2021, or (ii) the day prior to the date of the Annual Meeting next following October 12, 2020, subject to the reporting person's continued service. Read SEC document |
| January 06, 2020 Filed Jan 8, 2020 17:35 UTC | Flyte Aviation, Inc. RMED · Entity 8648 | GrantStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $1.18 | $0.00 |
DisclosureSEC source: 0001209191-20-002575 · doc4.xml · derivative · entry 1 COLOMBATTO MARTIN J · CIK 0001208236 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2030-01-06 F1 · derivative.exercise_date: The Reporting Person has elected to receive his 2020 retainer compensation in stock option grants, rather than cash. Subject to the Reporting Person continuing to be a "Service Provider" (as defined in the Company's 2018 Equity Incentive Plan) through each vesting date, the shares shall vest as follows: 25% of the shares subject to the option shall vest quarterly on the fifth of the month immediately following the end of the quarter corresponding with the date of grant (i.e. April 5, 2020, July 5, 2020, October 5, 2020, and January 5, 2021), such that the shares shall be fully vested on January 5, 2021. Read SEC document |
| June 06, 2019 Filed Jun 7, 2019 17:44 UTC | Flyte Aviation, Inc. RMED · Entity 8648 | GrantCommon Stock | 29,850 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-035626 · doc4.xml · nonDerivative · entry 1 COLOMBATTO MARTIN J · CIK 0001208236 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,475 F1 · shares: Reported shares represents a grant of restricted stock units (the "RSUs") pursuant to Ra Medical Systems, Inc.'s 2018 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of Ra Medical Systems, Inc. common stock. The RSUs will vest on the earlier of (i) June 6, 2020, or (ii) the day prior to the date of the Annual Meeting next following June 6, 2019, subject to the reporting person's continued service. Read SEC document |
| October 04, 2018 Filed Oct 5, 2018 18:15 UTC | Flyte Aviation, Inc. RMED · Entity 8648 | GrantCommon Stock | 8,235 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-054439 · doc4.xml · nonDerivative · entry 1 COLOMBATTO MARTIN J · CIK 0001208236 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,625 F1 · shares: Reported shares are represented by restricted stock units ("RSUs"), and each RSU is the economic equivalent of one share of Ra Medical Systems, Inc. common stock. 1/3rd of the RSUs shall vest annually beginning on October 4, 2019 such that the RSUs will be fully vested on October 4, 2021, subject to the reporting person's continued service. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.